Ultragenyx Pharmaceutical Inc. is in its Rahu mahadasha (3 Nov 2018 to 2 Nov 2036), Mercury antardasha (16 Oct 2026 to 4 May 2029) and Mercury pratyantar (16 Oct 2026 to 25 Feb 2027).
Next: pratyantar Ketu from 25 Feb 2027; antardasha Ketu from 4 May 2029; mahadasha Jupiter from 2 Nov 2036.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Makara (Capricorn) | 17°36′ | 1st | Shravana 3 |
| Moon | Makara (Capricorn) | 27°36′ | 1st | Dhanishta 2 |
| Mars | Kanya (Virgo) | 29°00′ | 9th | Chitra 2 |
| Mercury | Kumbha (Aquarius) | 5°57′ | 2nd | Dhanishta 4 |
| Jupiter (R) | Mithuna (Gemini) | 18°14′ | 6th | Ardra 4 |
| Venus (R) | Dhanu (Sagittarius) | 19°31′ | 12th | Purva Ashadha 2 |
| Saturn | Tula (Libra) | 28°30′ | 10th | Vishakha 3 |
| Rahu | Tula (Libra) | 8°36′ | 10th | Swati 1 |
| Ketu | Mesha (Aries) | 8°36′ | 4th | Ashwini 3 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how RARE moved in each period against the S&P 500, transits, fundamentals and news.